Angle Share Discussion Threads

[john henry] 22/1/2024 15:15

Recent clinical results is more Jam tomorrow. Market taking the Jam out of the price.

[john henry] 22/1/2024 14:42

Direction of least resistance is down , virtually no buyers. Sellers will appear as the price grinds down to the gap.
9 times out of 10 gaps get filled. AGL is showing a lot of weakness gap will be filled.
Aimho

[bones699] 22/1/2024 14:02

It doesn't generate much revenue and certainly very little through testing mainly research use revenues.

[miavoce] 22/1/2024 13:31

Ok, so if labs can't use parsortix how do Angle generate any revenue at all ?

[bones699] 22/1/2024 13:28

Miavoce

Just making stuff now get back to school!

Parsortix is not fully approved for lab testing ffs!

[muffster] 22/1/2024 12:26

Bone idle, put your amazing talents to work elsewhere. You're wasted here

[sicilian_kan] 22/1/2024 12:25

miavoce, the "breakthrough" RNS also stated: "ANGLE will also be working with key opinion leaders (KOLs) and clinicians to expedite the clinical adoption of the combined molecular profiling approach, including the formal establishment of performance under analytical conditions, and through carefully designed clinical studies to build on the promising patient cohort data presented."

[miavoce] 22/1/2024 12:01

Bones, research labs, pharma labs etc can all use Parsortix irrespective of the approval position. Plenty of scope there. You might do well to do some research yourself to better understand things before making comments.

[bones699] 22/1/2024 11:55

Miavoce

How does that work Parsortix is not approved by the FDA..where are these extra revenues you claim will come from Parsortix isn't fully approved for testing samples.

[dave4545] 22/1/2024 11:51

No chance, not enough sellers to get that low and plenty of nibblers on dips, it's just been traded for coppers hence the flows of buys then sales then buys.

[miavoce] 22/1/2024 11:30

Hi PAAT

Illumina can generate additional income purely by promoting the analysis of CTC's harvested using Parsortix. This would increase the sales of their testing kits. There is no need for Illumina to do any research at this stage. A sales tie-up between Illumina and Angle, where Illumina get a cut of any Parsortix sales that arise from their sales activity would also generate income for Illumina. This would be a win-win for Angle and Illumina.

[bones699] 22/1/2024 11:21

Market has sensed its being duped share price down 10% and falling!

[bones699] 22/1/2024 11:19

I agree these RNS's feel like an attempt by AN to keep the share price afloat ahead of an imminent cash raise because the likely £6m additional revenues are now at risk so he's prepping the ground with investors.

The recent RNS's contain little in the way of useful information, no financials, often just pat on the backs followed with a list of caveats such as 'potentially', 'subject to more reviews', 'may' etc etc nothing solid or robust!

[purchaseatthetop] 22/1/2024 10:57

Burmuda. It was a throw away comment based on my belief that only a revenue RNS now counts. There seems great expectation that the likes of Illumina will ride to the rescue. I doubt it. A close relative works for them and they are cancelling all overhead snd R@D. They cancelled the R@D interns this year and even a company trip to Amsterdam. AGL cash runs to Q2 25 if they hit their 2024 revenue targets. But it is far closer if they do not.

I just don’t trust AN.

[john henry] 22/1/2024 10:51

Dave, market is gonna test the gap 14 - 15.5p

[gspanner] 22/1/2024 10:12

So are we waiting for the ‘suck the sellers in’, providing some liquidity for the mm’s to sell to their larger buyers game again!

[bones699] 22/1/2024 08:39

From the LSE BB!

TwoGood2Die

Posts: 1,538

Price: 19.50

No Opinion

RE: Potentially?

Today 08:19

"RNS releases should only be used for dissemination of clear facts and information which are price sensitive to the market.

Today's RNS just creates share price volatility leaving the market to second guess what all this really means in terms of will it be successfull, on likely timelines before formal FDA approval is granted, and trying to second guess what the revenues and likely cashflow will be.

There seems to be a running theme with AGL releasing RNS's which contain few facts and even fewer financials."

"As the revolution in 'omics' data evolves, the importance of CTCs to extract genomic and phenotypic profiling information is becoming increasingly evident, providing valuable and potentially actionable data that, subject to further study, may be used to guide patient management decisions in a way that is not possible using only ctDNA."

[bones699] 22/1/2024 08:33

sawney

Pot....Kettle...Black...Tw@t!

Deltic Energy - Low risk / High Impact Exploration - Post 556DELT Deltic Energy Plc

sawney 22 Jan 2024 06:21 2

"In the cold light of day I expect Labour to cool down on the rhetoric about NS oil and gas...there are already signs that they're backtracking on"

[purchaseatthetop] 22/1/2024 08:20

The problem with this kind of RNS is that it suggests there is no near term potential RNS with £ values on it. Hence the price drop.

[sawney] 22/1/2024 08:12

Ah...the angelic Bonehead is back to start the week...

The voice of true altruism...or is it autism...

[bones699] 22/1/2024 07:57

I like these ramping type RNS's as rightly commented earlier no financials with the key words 'potential' yeh well patients don't want this might 'potentially' work or 'potentially' not work they want facts, they want assurances, no risks, if, could be's, buts!

My earlier post was very relevant the FDA given the recent scandel and fall out regarding Theranos Inc are not going to formally approve Parsortix for many months!

Hence with no revenues where is all the cash going to come from to keep the lights on...guess who...you guys...hence today's RNS!

[thiopia] 22/1/2024 07:40

I like AN news management when he is on a roll and on the IR campaign trail [Jab, Jab, Punch, Jab, Jab, Punch... I get the feeling he's about to land a haymaker knockout blow soon]

For our American listeners watching in black & white the American football analogy might be the blocking and tackling before the quarterback throws the touchdown pass or in American baseball the hitting of singles to load the bases before the star hitter hits a home run... [That's enough rubbish sports analogies - Ed]


02/01/2024 07:00 UKREG Angle PLC Contract announcement with Eisai Inc.

04/01/2024 07:00 UKREG Angle PLC Breakthrough clinical results

22/01/2024 07:00 RNSNON Angle PLC Potential utility in precision oncology

...

23/01/2024 ?
24/01/2024 ?
25/01/2024 ?

[bagpuss67] 22/1/2024 07:36

They have cash for now. But agreed they could do with more lab contracts or a partnership. Ovarian and Prostate appear to be in the long grass and this BiDetect years off so it's down to the lab business to mitigate how much cash will need to be raised (or not!!)